Venditti, A., Piciocchi, A., Palmieri, R., Arena, V., Candoni, A., Calafiore, V., et al. (2021). Results of the 6-Year Follow-up of the Gimema AML1310 Trial: A Risk-Adapted, MRD-Directed Therapy for Young Adults with Newly Diagnosed Acute Myeloid Leukemia. Intervento presentato a: 63rd ASH Annual Meeting and Exposition - Dec 11, 2021 - Dec 14, 2021, Atlanta, GA, United States [10.1182/blood-2021-147200].

Results of the 6-Year Follow-up of the Gimema AML1310 Trial: A Risk-Adapted, MRD-Directed Therapy for Young Adults with Newly Diagnosed Acute Myeloid Leukemia

Cairoli, Roberto;
2021

abstract + poster
Hematology
English
63rd ASH Annual Meeting and Exposition - Dec 11, 2021 - Dec 14, 2021
2021
2021
138
S1
2359
2359
https://ashpublications.org/blood/article/138/Supplement 1/2359/478816/Results-of-the-6-Year-Follow-up-of-the-Gimema
none
Venditti, A., Piciocchi, A., Palmieri, R., Arena, V., Candoni, A., Calafiore, V., et al. (2021). Results of the 6-Year Follow-up of the Gimema AML1310 Trial: A Risk-Adapted, MRD-Directed Therapy for Young Adults with Newly Diagnosed Acute Myeloid Leukemia. Intervento presentato a: 63rd ASH Annual Meeting and Exposition - Dec 11, 2021 - Dec 14, 2021, Atlanta, GA, United States [10.1182/blood-2021-147200].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/409336
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 3
Social impact